Transgenic mouse model for studying the transcriptional activity of the p53 protein: Age- and tissue-dependent changes in radiation-induced activation during embryogenesis

被引:144
作者
Gottlieb, E
Haffner, R
King, A
Asher, G
Gruss, P
Lonai, P
Oren, M
机构
[1] WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL
[2] WEIZMANN INST SCI,DEPT MOL GENET,IL-76100 REHOVOT,ISRAEL
[3] MAX PLANCK INST BIOPHYS CHEM,D-37018 GOTTINGEN,GERMANY
关键词
embryogenesis; mdm2; p53; transcriptional activation; transgenics;
D O I
10.1093/emboj/16.6.1381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor protein is a sequence-specific transcriptional activator of target genes, Exposure of cells to DNA damage results in accumulation of biochemically active p53, with consequent activation of p53-responsive promoters, In order to study how the transcriptional activity of the p53 protein is regulated in vivo, a transgenic mouse strain was generated, These mice harbor the p53-dependent promoter of the mdm2 gene, fused to a lacZ reporter gene. Induction of lacZ activity by DNA damage (ionizing radiation) was monitored in embryos of different p53 genotypes, The transgenic promoter was substantially activated in vivo following irradiation; activation required functional p53, The activation pattern became more restricted with increasing embryo age, as well as with the state of differentiation of a given tissue, Generally, maximal p53 activation occurred in rapidly proliferating, relatively less differentiated cells, A striking extent of haploinsufficiency was revealed-induction of promoter activity was far less efficient in mice carrying only one wild-type p53 allele, This suggests that normal levels of cellular p53 are limiting, and any further reduction already compromises the p53 response significantly, Thus, the activation potential of p53 is tightly controlled in vivo, both spatially and temporally, and an important element in this control is the presence of limiting basal levels of activatable p53.
引用
收藏
页码:1381 / 1390
页数:10
相关论文
共 61 条
  • [21] TUMOR SPECTRUM ANALYSIS IN P53-MUTANT MICE
    JACKS, T
    REMINGTON, L
    WILLIAMS, BO
    SCHMITT, EM
    HALACHMI, S
    BRONSON, RT
    WEINBERG, RA
    [J]. CURRENT BIOLOGY, 1994, 4 (01) : 1 - 7
  • [22] Cell-cycle control and its watchman
    Jacks, T
    Weinberg, RA
    [J]. NATURE, 1996, 381 (6584) : 643 - 644
  • [23] JUVEN T, 1993, ONCOGENE, V8, P3411
  • [24] A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA
    KASTAN, MB
    ZHAN, QM
    ELDEIRY, WS
    CARRIER, F
    JACKS, T
    WALSH, WV
    PLUNKETT, BS
    VOGELSTEIN, B
    FORNACE, AJ
    [J]. CELL, 1992, 71 (04) : 587 - 597
  • [25] KASTAN MB, 1991, CANCER RES, V51, P6304
  • [26] P53-DEFICIENT MICE ARE EXTREMELY SUSCEPTIBLE TO RADIATION-INDUCED TUMORIGENESIS
    KEMP, CJ
    WHELDON, T
    BALMAIN, A
    [J]. NATURE GENETICS, 1994, 8 (01) : 66 - 69
  • [27] REDUCTION OF P53 GENE DOSAGE DOES NOT INCREASE INITIATION OR PROMOTION BUT ENHANCES MALIGNANT PROGRESSION OF CHEMICALLY-INDUCED SKIN TUMORS
    KEMP, CJ
    DONEHOWER, LA
    BRADLEY, A
    BALMAIN, A
    [J]. CELL, 1993, 74 (05) : 813 - 822
  • [28] p53: Puzzle and paradigm
    Ko, LJ
    Prives, C
    [J]. GENES & DEVELOPMENT, 1996, 10 (09) : 1054 - 1072
  • [29] Transgenic mice with p53-responsive lacZ: P53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo
    Komarova, EA
    Chernov, MV
    Franks, R
    Wang, KH
    Armin, G
    Zelnick, CR
    Chin, DM
    Bacus, SS
    Stark, GR
    Gudkov, AV
    [J]. EMBO JOURNAL, 1997, 16 (06) : 1391 - 1400
  • [30] CANCER - P53, GUARDIAN OF THE GENOME
    LANE, DP
    [J]. NATURE, 1992, 358 (6381) : 15 - 16